#BharatBiotech Submitted Data from Clinical Trials in the 2-18 Years Age Group for ... - Latest Tweet by DD News
The latest Tweet by DD News states, '#BharatBiotech submitted data from clinical trials in the 2-18 years age group for #COVAXIN to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee and have provided their positive recommendations'
#BharatBiotech submitted data from clinical trials in the 2-18 years age group for #COVAXIN (BBV152) to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) and have provided their positive recommendations pic.twitter.com/eqdTWgcJS9— DD News (@DDNewslive) October 12, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Oct 12, 2021 03:54 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
